SCHEDULE 13G/A: Thomas A. Satterfield, Jr. Discloses 9.9% Stake in Curis, Inc., Potential for Over 20% Ownership

Thomas A. Satterfield, Jr. has filed an amended Schedule 13G, reporting a 9.9% beneficial ownership stake in Curis, Inc., with the potential to hold 20.8% if warrant exercise limitations were removed.

Summary

• Thomas A. Satterfield, Jr. beneficially owns an aggregate of 1,035,762 shares of Curis, Inc. common stock as of March 31, 2025.
• This ownership represents 9.9% of Curis, Inc.'s outstanding common stock.
• The calculation of the 9.9% stake is based on 8,487,818 shares outstanding as of March 27, 2025, and an additional 1,974,432 shares sold by the issuer as reported on March 28, 2025, totaling 10,462,250 shares.
• Mr. Satterfield holds common stock, warrants, and pre-funded warrants, all subject to a 9.99% beneficial ownership exercise limitation.
• If the 9.99% exercise limitation on warrants and pre-funded warrants were not in place, Mr. Satterfield would be deemed the beneficial owner of 2,481,924 shares, representing 20.8% of the issuer's outstanding common stock.
• The shares are held across various entities: Tomsat Investment & Trading Co., Inc. (wholly owned by Mr. Satterfield), A.G. Family L.P. (managed by a general partner controlled by Mr. Satterfield), and Caldwell Mill Opportunity Fund, LLC (managed by an entity where Mr. Satterfield owns a 50% interest and serves as Chief Investment Manager).

Sentiment

Score: 6

Explanation: The sentiment is moderately positive. While a 13G is a passive filing, the disclosure of a significant stake (9.9%) by an individual investor, coupled with the potential for a much larger stake (20.8%) if exercise limits were removed, suggests a strong, long-term interest in the company. This can be viewed favorably by the market as a vote of confidence.

Positives

• A significant beneficial ownership stake (9.9%) by an individual investor, Thomas A. Satterfield, Jr., indicates a notable level of confidence in Curis, Inc.
• The potential for Mr. Satterfield's ownership to increase to 20.8% if exercise limitations were removed suggests a substantial long-term interest in the company's performance.

Risks

• The existence of warrants and pre-funded warrants with a 9.99% exercise limitation means that a significant portion of Mr. Satterfield's potential ownership is not immediately convertible into common stock, which could affect his voting power or influence until those limits are removed or waived.
• The potential for a large block of shares (20.8%) to be exercised in the future could lead to significant dilution for existing shareholders if and when the exercise limitations are lifted.

Future Outlook

The document does not provide forward-looking statements regarding the company's operational or financial performance, focusing solely on the reporting person's beneficial ownership.

Industry Context

This filing is a standard disclosure of a significant ownership stake in a publicly traded company, Curis, Inc., which operates in the biotechnology or pharmaceutical sector. Such filings are common for large individual or institutional investors and do not inherently provide broader industry trends or competitive analysis.

Related Party Transactions

• 207,411 shares of common stock, 332,294 shares issuable upon warrant exercise, and 53,251 shares issuable upon pre-funded warrant exercise are held by Tomsat Investment & Trading Co., Inc., a corporation wholly owned by Mr. Satterfield, who also serves as its President.
• 411,059 shares of common stock, 623,236 shares issuable upon warrant exercise, and 99,845 shares issuable upon pre-funded warrant exercise are held by A.G. Family L.P., a partnership managed by a general partner controlled by Mr. Satterfield.
• 240,000 shares of common stock are held by Caldwell Mill Opportunity Fund, LLC, which is managed by an entity where Mr. Satterfield owns a 50% interest and serves as Chief Investment Manager.
• 28,236 shares of common stock, 83,096 shares issuable upon warrant exercise, and 13,312 shares issuable upon pre-funded warrant exercise are held by Pontikes Holdings LLC, a limited liability company owned by Mr. Satterfield's stepbrother, though Mr. Satterfield disclaims beneficial ownership of these shares.

Stakeholder Impact

• Shareholders: The disclosure of a significant beneficial owner, especially one with potential for a much larger stake, can influence investor perception and potentially the stock's liquidity and trading dynamics. The potential future exercise of warrants could lead to dilution.
• Company Management: Awareness of a large, potentially increasing, shareholder stake may influence strategic decisions or engagement with the investor.

Key Dates

Keywords

Curis Inc., Thomas A. Satterfield Jr., Schedule 13G, Beneficial Ownership, Common Stock, Warrants, Pre-funded Warrants, SEC Filing, Shareholder Stake, Biotechnology, Pharmaceuticals